These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 17418938
1. Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy. Zwergel U, Suttmann H, Schroeder T, Siemer S, Wullich B, Kamradt J, Lehmann J, Stoeckle M. Eur Urol; 2007 Oct; 52(4):1058-65. PubMed ID: 17418938 [Abstract] [Full Text] [Related]
11. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L. BJU Int; 2008 Feb 01; 101(3):305-7. PubMed ID: 17941921 [Abstract] [Full Text] [Related]
12. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. BJU Int; 2008 Jan 01; 101(2):170-4. PubMed ID: 18173824 [Abstract] [Full Text] [Related]
13. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. BJU Int; 2008 Nov 01; 102(10):1413-8. PubMed ID: 18537951 [Abstract] [Full Text] [Related]
16. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Souchon R, Stöckle M, Rübe C, Weissbach L, Althaus P, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K. J Clin Oncol; 2009 Jun 20; 27(18):2924-30. PubMed ID: 19433689 [Abstract] [Full Text] [Related]
18. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer. Yamamoto S, Kawakami S, Yonese J, Fujii Y, Ohkubo Y, Suyama T, Komai Y, Kijima T, Ishikawa Y, Fukui I. Int J Urol; 2008 Oct 20; 15(10):895-9. PubMed ID: 18721204 [Abstract] [Full Text] [Related]